A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.

Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan B. · 2022

Read A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. by Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan B. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9033817.txt.

Description

Koppula and co-authors found a shield that lets some lung cancers resist both ferroptosis and radiation. Cancers with an inactive KEAP1 gene are hard to treat and shrug off radiotherapy. The team showed that these cells lean on FSP1, a protein switched on by the NRF2 pathway. FSP1 uses coenzyme Q to block the lipid damage that drives ferroptosis.

Blocking the CoQ-FSP1 axis made the cancer cells and patient-derived tumors sensitive to radiation again. Cell death rose sharply once the shield was removed. The authors propose this axis as a drug target for KEAP1-mutant lung cancers.

Catalog record

CREATORKoppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan B.
YEAR2022
COLLECTIONPAPERS
FORMATTXT
FILE SIZE72 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9033817

Browse the full library · About the Tower of Babel